Innovation & Technology transfer

Four companies have been created since launch of the program.

Resilience : a mobile application to better manage the disease.

www.resilience.care

ORAKL : development of functional in vitro diagnostic tests, “organograms”, to predict the responses of cancers to drugs.

www.orakl-oncology.com

Cure51 : learning from cancer survivors

www.cure51.com

Elikya Therapeutics : innovative molecules for cancer treatment.

 Prism is a one-of-a kind partnership between

Label

Centre National de Médecine de Précision en Oncologie

Where to find us

Prism  IHU-B

Bâtiment de médecine moléculaire

32 Rue Camille Desmoulins

94800 Villejuif

Tél. +33(0)1 42 11 00 00

info -at- prism.center

Liens

Press

Work with us

Call for project

Accessibility

Cookies

Legal notice

Connect with us